Reference Medicine(s) Quantity ingested (blood concentration) Outcome Our case moclobemide venlafaxine 4500 mg (41 mg/L) 3000 mg (5.8 mg/L) favorable  [5] moclobemide venlafaxine 1800 mg (24.4 mg/L) 1800 mg (0.7 mg/L) death  [9] moclobemide venlafaxine 3000 mg 2625 mg favorable  [16,17] moclobemide high dose favorable  [10] moclobemide paroxétine (18.5 mg/L) (1.58 mg/L) death  [27] venlafaxine lamotrigine diazépam 4500 mg (1.2 mg/L) 20 g (42.4 mg/L) 200 mg (0.56 mg/L) favorable  [31] sertraline 1500 mg favorable  [32] milnacipran 3000 mg (8.4 mg/L) favorable  [33] tramadol citalopram therapeutic doses favorable  [34] venlafaxine mirtazapine 150 mg 30 mg favorable  [35] citalopram oxycodone 50 mg 20 mg favorable  [36] tramadol oxycodone bupropion trazodone 400 mg 10-20 mg 300 mg 25 mg favorable  [37] fentanyl amitriptyline linézolide 25 µg/h 25 mg 600 mg favorable  [38] lithium venlafaxine therapeutic doses favorable  [39] lithium paroxétine 400 mg (0.63 mmol/L) 30 mg (0.693 mg/L) favorable   [40] électroconvulsivothérapie paroxétine - 40 mg favorable  [41] MDMA 3 tablets favorable  [42] MDMA moclobemide (1.7 mg/L) (2.6 mg/L) (1 mg/L) (2.0 mg/L) 4 deaths (0.3 mg/L) (0.7 mg/L) (15 mg/L) (8.7 mg/L)  [43] méthylone butylone 844 mg 106 mg death

Table 1: Serotonin Syndromes reported in the literature: medicines involved, quantities ingested and corresponding blood concentrations, evolution of the patient.